Impact of cyclosporine 2‐h level and mycophenolate mofetil dose on clinical outcomes in de novo heart transplant patients receiving anti‐thymocyte globulin induction (Q44412745)

From Wikidata
Jump to navigation Jump to search
scientific article published on April 1, 2003
edit
Language Label Description Also known as
English
Impact of cyclosporine 2‐h level and mycophenolate mofetil dose on clinical outcomes in de novo heart transplant patients receiving anti‐thymocyte globulin induction
scientific article published on April 1, 2003

    Statements

    Impact of cyclosporine 2-h level and mycophenolate mofetil dose on clinical outcomes in de novo heart transplant patients receiving anti-thymocyte globulin induction (English)
    Impact of cyclosporine 2‐h level and mycophenolate mofetil dose on clinical outcomes in de novo heart transplant patients receiving anti‐thymocyte globulin induction (English)
    Marcelo Cantarovich
    Nadia Giannetti
    Renzo Cecere
    1 April 2003
    144-150

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit